Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data
Contributors
Cooper, Cyrus; Bardin, Thomas; Brandi, Maria-Luisa; Cacoub, Patrice; Caminis, John; Civitelli, Roberto; Cutolo, Maurizio; Dere, Willard; Devogelaer, Jean-Pierre; Diez-Perez, Adolfo; Einhorn, Thomas A.; Emonts, Patrick; Ethgen, Olivier; Kanis, John A.; Kaufman, Jean-Marc; Kvien, Tore K.; Lems, Willem F.; McCloskey, Eugene; Miossec, Pierre; Reiter, Susanne; Ringe, Johann; Rizzoli, René; Saag, Kenneth; Reginster, Jean-YvesPublished in
Aging Clinical and Experimental Research, vol. 28, no. 1, p. 1-16Publication date
2016Note
Complément du titre : An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
COOPER, Cyrus et al. Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. In: Aging Clinical and Experimental Research, 2016, vol. 28, n° 1, p. 1–16. doi: 10.1007/s40520-015-0522-1
Main files (1)
Article (Published version)
Identifiers
- PID : unige:81058
- DOI : 10.1007/s40520-015-0522-1
